Could a pill replace an IV for advanced breast cancer treatment?
NCT ID NCT07684456
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This Phase 3 trial compares two forms of the chemotherapy drug utidelone—a capsule taken by mouth versus an injection—both combined with another chemo drug, capecitabine, in people with HER-2 negative advanced breast cancer. The study aims to see if the oral capsule works as well as the injection at delaying cancer growth. About 308 participants with advanced or metastatic breast cancer are being enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Utidelone (a chemotherapy drug) given as a capsule or injection, combined with capecitabine
- What this could lead to
- If successful, this could provide a more convenient oral option for treating advanced breast cancer, potentially improving quality of life while controlling the disease.
- What could go wrong
- This is a Phase 3 trial, but results may not show a significant benefit over existing treatments. Side effects from chemotherapy, such as nausea, fatigue, and nerve damage, are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood tests could reveal hidden resistance in breast cancer
- Triple threat: three new targeted drugs join forces with immunotherapy to attack Hard-to-Treat breast cancer
- New drug sequence aims to outsmart advanced breast cancer
- Blood test timing could unlock secrets of advanced breast cancer
- Oral chemotherapy pill tested for advanced breast cancer
- New oral drug aims to tackle Hormone-Driven cancers